Documents & Downloads

BMY 20844

cAMP Phosphodiesterase Inhibitor

BMY 20844 is an orally active inhibitor of cAMP phosphodiesterase that exhibits significant anti-thrombotic activity. By elevating cAMP levels, BMY 20844 activates protein kinase within platelets, thereby influencing platelet aggregation and function. This compound is valuable for research aimed at understanding and developing therapies for cardiovascular diseases.

Out of Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer	Adooq Bioscience
Actions	Inhibitor
CAS Number	124886-01-7
Applications	cAMP Phosphodiesterase Inhibitor
Formula	C₁₂H₁₁N₃O
Molecular Weight	213.24
SMILES	O=C1N=C2NC3=CC=C(C)C(C)=C3C=C2N1

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.